Updates are available Correction dated 2020-01-15
Click to view Correction: https://doi.org/10.1038/s41598-020-57442-8
-
Authors
Epeldegui, Marta
Conti, David V.
Guo, Yu
Cozen, Wendy
Penichet, Manuel L.
MartÃnez-Maza, Otoniel
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA168482-S, R21-CA220475, R01-CA196266)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (P30-AI028697-S)
- License Information
-
More Information
Article History
Received: 15 October 2018
Accepted: 5 June 2019
First Online: 28 June 2019
Change Date: 15 January 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing Interests
: Dr. Manuel L. Penichet is a shareholder of Klyss Biotech, Inc. The Regents of the University of California are in discussions with Klyss to license Dr. Penichet’s technology to this firm. Other authors have no conflict of interest.
